US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.49

+0.920020.13%

Post-market: 5.570.0800+1.46%19:59 EDT

Volume:60.32M

Turnover:318.68M

Market Cap:2.23B

PE:-3.02

High:5.52

Open:4.72

Low:4.71

Close:4.57

Loading ...

Overview Company News Filings

Recursion Pharmaceuticals (NasdaqGS:RXRX) Reports Q1 Sales Increase and REC-4881 Trial Results

Simply Wall St.

Shares of Recursion Pharmaceuticals Slide After 1Q Loss

Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results

THOMSON REUTERS

Recursion Pharmaceuticals Q1 Loss Widens, Revenue Increases

MT Newswires Live

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M

MT Newswires Live

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live

Recursion Pharmaceuticals Q1 EPS USD -0.5

THOMSON REUTERS

Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate

Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial

MT Newswires Live

Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress

Nvidia-Related Stocks Shined. Aurora Jumped 8%; CoreWeave And WeRide Up 7%; Innoviz Up 4%; Nvidia Up 2%

Tiger Newspress

Nvidia-Related and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; AppLovin up 6%; Nvidia up 4%

Tiger Newspress

Nvidia-Concept Stocks Shined. CoreWeave Up 8%; Nebius Up 6%; Innoviz Up 5%; Nvidia Up 3%

Tiger Newspress

Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

Press Release: Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards?

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

Recursion Pharmaceuticals (RXRX) Stock Moves -1.64%: What You Should Know

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RXRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RXRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXRX\",,,,,undefined,":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":5.49,"timestamp":1749240000000,"preClose":4.57,"halted":0,"volume":60322738,"hourTrading":{"tag":"盘后","latestPrice":5.57,"preClose":5.49,"latestTime":"19:59 EDT","volume":805749,"amount":4452178.8127,"timestamp":1749254398932},"delay":0,"floatShares":388599465,"shares":406916486,"eps":-1.819511,"marketStatus":"Market Closed","change":0.92,"latestTime":"06-06 16:00:00 EDT","open":4.72,"high":5.52,"low":4.705,"amount":318680621.294126,"amplitude":0.178337,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.819511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":4.57,"preHourTrading":{"tag":"盘前","latestPrice":4.71,"preClose":4.57,"latestTime":"09:29 EDT","volume":531002,"amount":2474617.0978566,"timestamp":1749216599999},"postHourTrading":{"tag":"盘后","latestPrice":5.57,"preClose":5.49,"latestTime":"19:59 EDT","volume":805749,"amount":4452178.8127,"timestamp":1749254398932},"volumeRatio":2.2333599123674692,"optionData":{"bulkOrders":[{"symbol":"RXRX","call":true,"expireDate":1750392000000,"strike":"6.0","timestamp":1749222306115,"price":0.34,"volume":3999,"amount":135966,"type":"+"},{"symbol":"RXRX","call":true,"expireDate":1749787200000,"strike":"5.0","timestamp":1749222109604,"price":0.55,"volume":2938,"amount":161590,"type":"+"}]},"impliedVol":1.0033,"impliedVolPercentile":0.784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXRX\",,,,,undefined,":{"symbol":"RXRX","floatShares":388599465,"roa":"-38.51%","roe":"-86.10%","lyrEps":-1.690915,"volumeRatio":2.2333599123674692,"shares":406916486,"dividePrice":0,"high":5.52,"amplitude":0.178337,"preClose":4.57,"low":4.705,"week52Low":3.79,"pbRate":"2.39","psRate":"37.36","week52High":12.36,"institutionHeld":0,"latestPrice":5.49,"eps":-1.819511,"divideRate":0,"volume":60322738,"delay":0,"ttmEps":-1.819511,"open":4.72,"prevYearClose":6.76,"prevWeekClose":4.18,"prevMonthClose":4.18,"prevQuarterClose":5.29,"fiveDayClose":4.18,"twentyDayClose":4.39,"sixtyDayClose":6.17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RXRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533555696","title":"Recursion Pharmaceuticals (NasdaqGS:RXRX) Reports Q1 Sales Increase and REC-4881 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533555696","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533555696?lang=en_us&edition=fundamental","pubTime":"2025-05-06 01:17","pubTimestamp":1746465425,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals has demonstrated resilience amid recent financial challenges, with the stock experiencing a 34% increase over the last month. This notable price movement may reflect the market's positive reception to promising developments in their Phase 1b/2 TUPELO trial for REC-4881, despite reporting a significant net loss increase. The trial results showing a 43% reduction in polyp burden for FAP and regulatory recognition of REC-4881 highlight the company's focus on addressing rare diseases. While broader market trends remained largely stable, Recursion's performance illustrates its potential appeal to investors amidst a mixed company earnings landscape.We've spotted 4 weaknesses for Recursion Pharmaceuticals you should be aware of, and 2 of them make us uncomfortable.NasdaqGS:RXRX Earnings Per Share Growth as at May 2025. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased metho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-nasdaqgs-rxrx-reports-171705129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX","REC"],"gpt_icon":1},{"id":"2533371155","title":"Shares of Recursion Pharmaceuticals Slide After 1Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2533371155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533371155?lang=en_us&edition=fundamental","pubTime":"2025-05-06 00:21","pubTimestamp":1746462060,"startTime":"0","endTime":"0","summary":"Shares of Recursion Pharmaceuticals fell after the company reported a first-quarter loss.Shares slid 13.4% to $4.94 during Monday's trading, and the stock is down 27% year to date.The clinical stage biotechnology company reported a first-quarter loss of $202.5 million, or 50 cents a share, compared with $91.4 million, or 39 cents a share, a year earlier.Analysts polled by FactSet were expecting a loss of 52 cents a share.Revenue grew to $14.7 million from $13.8 million during the year-ago quarter. Analysts were expecting $15 million.The Salt Lake City-based company said its research and development expenses rose to $130 million from $68 million during the year-ago quarter, driven primarily by an agreement with Tempus and a business combination with Exscientia.Recursion had a cash position of $509 million as of March 31, compared with $603 million on Dec. 31, 2024.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4539","BK4611","BK4548","RXRX","BK4139"],"gpt_icon":1},{"id":"2533589134","title":"Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589134?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:32","pubTimestamp":1746448360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4N3RD0QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","RXRX","BK4539","BK4611","BK4139","BK4548"],"gpt_icon":0},{"id":"2533300342","title":"Recursion Pharmaceuticals Q1 Loss Widens, Revenue Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533300342?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:48","pubTimestamp":1746442092,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  reported a Q1 net loss Monday of $0.50 per diluted share, widening from a loss of $0.39 a year earlier.Analysts polled by FactSet expected a loss of $0.39.Revenue for the quarter ended March 31 was $14.7 million, up from $13.7 million a year earlier.Analysts surveyed by FactSet expected $15 million.Recursion shares were down 4.5% in recent premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533302313","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533302313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533302313?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:13","pubTimestamp":1746439997,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533630231","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2533630231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533630231?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:12","pubTimestamp":1746439950,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533042003","title":"Recursion Pharmaceuticals Q1 EPS USD -0.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2533042003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533042003?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:04","pubTimestamp":1746439446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLX528C70:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","RXRX","BK4609","BK4139","BK4611","BK4539"],"gpt_icon":0},{"id":"2533830235","title":"Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533830235","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533830235?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:01","pubTimestamp":1746439299,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.52) by 3.85 percent. This is a 28.21 percent decrease over losses of $(0.39) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45189433/recursion-pharmaceuticals-q1-eps-0-50-beats-0-52-estimate-sales-14-74m-miss-18-12m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":1},{"id":"2533303765","title":"Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533303765","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533303765?lang=en_us&edition=fundamental","pubTime":"2025-05-05 16:10","pubTimestamp":1746432624,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  said Sunday early results from a phase 1/2 trial of its drug REC-4881 for Familial Adenomatous Polyposis showed a median reduction in polyp burden of 43% after 13 weeks among six patients who were evaluated.The company said five patients saw polyp reductions between 31% and 82%, while one experienced a sharp increase compared to  20% to 30% reductions in other drugs over six months.Three patients also showed improvement in the Spigelman stage, while one worsened and two had mixed or unclear results.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4609","RXRX","BK4539","BK4611","BK4139","BK4548"],"gpt_icon":1},{"id":"2533324588","title":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis","url":"https://stock-news.laohu8.com/highlight/detail?id=2533324588","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533324588?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377116,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on May 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250504:nNDL4zwyhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","RXRX","BK4588","NDAQ","BK4609","BK4539","IE00BKPKM429.USD","LU2210149790.SGD","BK4611","BK4112","LU2095319765.USD","BK4139","LU2210150020.SGD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4548"],"gpt_icon":1},{"id":"2533334128","title":"Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=2533334128","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533334128?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377100,"startTime":"0","endTime":"0","summary":"In the Phase 2 open-label study, REC-4881  led to a median 43% reduction  in polyp burden at the Week 13 assessment at time of data cutoff.Five of six patients (83%) experienced reductions in polyp burden ranging from 31% to 82%, however, one patient showed a substantial increase from baseline.The early safety profile of REC-4881 was generally consistent with that of prior MEK1/2 inhibitors; among 19 patients across Phase 1b and 2, most treatment-related adverse events were Grade 1 or 2, with Grade 3 events in 16% of patients and no Grade ≥4 TRAEs reported to date.Across the combined Phase 1b and ongoing Phase 2 cohorts , REC-4881 demonstrated an early safety profile generally consistent with that of prior MEK1/2 inhibitors. Seventy-nine percent  of patients experienced at least one treatment-related adverse event , the majority of which were Grade 1 or 2 in severity. Grade 3 TRAEs occurred in 16% of patients, with no Grade ≥4 events reported to date. In Phase 1b, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/preliminary-phase-1b-2-data-164500686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4611","CPK","BK4181","BK4197","BK4539","BK4218","BK4609","TRAE","REC","PK","BK4548","RXRX"],"gpt_icon":1},{"id":"1163309579","title":"Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1163309579","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163309579?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:57","pubTimestamp":1746194225,"startTime":"0","endTime":"0","summary":"Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","BEAM","CRSP","ABSI","TXG","RXRX","DNA","RBOT"],"gpt_icon":0},{"id":"1126823213","title":"Nvidia-Related Stocks Shined. Aurora Jumped 8%; CoreWeave And WeRide Up 7%; Innoviz Up 4%; Nvidia Up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126823213","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126823213?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:44","pubTimestamp":1746193484,"startTime":"0","endTime":"0","summary":"Nvidia-Related Stocks Shined. Aurora jumped 8%; CoreWeave and WeRide up 7%; Innoviz up 4%; Nvidia up 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVZ","RXRX","APLD","ARBE","CRNC","ARM","SERV","NNOX","NVDA","AUR","MU","TM","NBIS","SOUN"],"gpt_icon":0},{"id":"1182359128","title":"Nvidia-Related and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; AppLovin up 6%; Nvidia up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182359128","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182359128?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:29","pubTimestamp":1746109787,"startTime":"0","endTime":"0","summary":"Nvidia-Related Stocks and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; Nebius up 8%; AppLovin up 6%; Nvidia and Innoviz up 4%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOUN","UPST","AI","INVZ","CRNC","AUR","ARM","NBIS","RBRK","NVDA","APLD","RXRX","HUBS","TM","BIDU","PLTR","NNOX","ARBE","SERV","TEM","APP","ISRG","BRZE","MU"],"gpt_icon":0},{"id":"1132809281","title":"Nvidia-Concept Stocks Shined. CoreWeave Up 8%; Nebius Up 6%; Innoviz Up 5%; Nvidia Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132809281","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132809281?lang=en_us&edition=fundamental","pubTime":"2025-05-01 16:43","pubTimestamp":1746089013,"startTime":"0","endTime":"0","summary":"Nvidia-concept stocks shined. CoreWeave up 8%; Nebius up 6%; Innoviz up 5%; Nvidia up 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLD","CRNC","INVZ","ARBE","SERV","NBIS","NNOX","SOUN","RXRX","MU","NVDA","ARM","TM","CRWV","AUR"],"gpt_icon":0},{"id":"2531296670","title":"Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296670","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531296670?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:50","pubTimestamp":1745877015,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Recursion Pharmaceuticals  standing at $5.84, reflecting a +1.83% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.06%. Elsewhere, the Dow gained 0.28%, while the tech-heavy Nasdaq lost 0.1%.The biotechnology company's stock has dropped by 1.38% in the past month, exceeding the Medical sector's loss of 6.38% and the S&P 500's loss of 4.29%.Investors will be eagerly watching for the performance of Recursion Pharmaceuticals in its upcoming earnings disclosure. The company is expected to report EPS of -$0.44, down 12.82% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $20.15 million, indicating a 46.12% growth compared to the corresponding quarter of the prior year.It is also important to note the recent changes to analyst estimates for Recursion Pharmaceuticals. These latest adjustments often mirror the shifting dynamics of short-term busines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-surpasses-market-215015830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX","BK4611","BK4539","BK4548","BK4139","BK4609"],"gpt_icon":1},{"id":"2530440159","title":"Press Release: Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th","url":"https://stock-news.laohu8.com/highlight/detail?id=2530440159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530440159?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:27","pubTimestamp":1745843220,"startTime":"0","endTime":"0","summary":"Company to host public earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. Salt Lake City, UT, April 28, 2025  -- Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2025 financial results on Monday, May 5, 2025, before the open of the financial markets.Recursion  is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale -- up to millions of wet lab experiments weekly -- and massive c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4585","BK4139","BK4611","BK4548","LU0053666078.USD","BK4539","BK4609","BK4588","BK4107","L"],"gpt_icon":0},{"id":"2530686951","title":"Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530686951","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530686951?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:16","pubTimestamp":1745594160,"startTime":"0","endTime":"0","summary":"The Zacks Consensus Estimate is pegged at a loss of 44 cents per share. The Zacks Consensus Estimate for first-quarter revenues is pinned at $20.15 million.Let's see how things might have shaped up for the upcoming quarterly release.In the absence of a marketed product in the company’s commercial portfolio, Recursion Pharmaceuticals only recognizes collaboration and grant revenues from its partners.RXRX has ongoing collaboration agreements with pharma giants like Roche, Bayer, Merck and Sanofi to develop candidates for several oncology indications with differentiated mechanisms of action. The company also collaborated with NVIDIA Corporation, the worldwide leader in visual computing technologies, to build a next-generation platform for the company to develop novel therapies.Recursion Pharmaceuticals is expected to provide updates regarding the clinical-stage pipeline programs on its first-quarter earnings call. RXRX expects several data readouts throughout 2025.General and administrati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-report-q1-earnings-151600127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX"],"gpt_icon":1},{"id":"2529493595","title":"Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529493595","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529493595?lang=en_us&edition=fundamental","pubTime":"2025-04-23 08:34","pubTimestamp":1745368440,"startTime":"0","endTime":"0","summary":"Salt Lake City, UT, April 22, 2025  -- Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week  meeting from its ongoing Phase 1b/2 clinical trial, TUPELO, which is evaluating the safety and preliminary activity of REC-4881 for the treatment of familial adenomatous polyposis . The data will be presented as a late-breaking oral presentation during the Research Forum session on Hereditary GI cancer syndromes on Sunday, May 4, 2025 in San Diego.“We are pleased that DDW has recognized the importance of our data in addressing the unmet needs of the FAP patient population, where no FDA-approved therapies currently exist,” said Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. “MEK 1/2 inhibition for the potential treatment of FAP was identified through our AI-powered Recursion OS platform, which analyzed cellular models of APC gene loss to uncover a poten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-present-preliminary-clinical-data-003400160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","RXRX","BK4139","BK4539","TRAE","BK4611","BK4609","REC"],"gpt_icon":1},{"id":"2529571383","title":"Recursion Pharmaceuticals (RXRX) Stock Moves -1.64%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2529571383","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529571383?lang=en_us&edition=fundamental","pubTime":"2025-04-22 05:50","pubTimestamp":1745272232,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  closed the latest trading day at $5.41, indicating a -1.64% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 2.36%. At the same time, the Dow lost 2.48%, and the tech-heavy Nasdaq lost 2.55%.Prior to today's trading, shares of the biotechnology company had lost 17.67% over the past month. This has lagged the Medical sector's loss of 9.83% and the S&P 500's loss of 5.6% in that time.Market participants will be closely following the financial results of Recursion Pharmaceuticals in its upcoming release. The company's earnings per share  are projected to be -$0.44, reflecting a 12.82% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $20.15 million, indicating a 46.12% growth compared to the corresponding quarter of the prior year.Investors should also pay attention to any latest changes in analyst estimates for Recursion Pharmaceutical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-stock-moves-215032641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX","BK4609","BK4539","BK4139","BK4611","BK4548"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RXRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"RXRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2025-02-28","symbol":"RXRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-11-06","symbol":"RXRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-08-08","symbol":"RXRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2024-05-09","symbol":"RXRX","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RXRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RXRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":8,"updateTime":1744257600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RXRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RXRX","date":"2025-06-05","current":-3.476073,"percent":0.978346,"low":-70.058071,"twenty":-13.460985,"median":-6.801735,"eighty":-5.247374,"high":-2.888468,"avg":-12.552331,"sd":14.130598,"marketCap":1997959946},"quantilePoints":[{"date":"2021-04-16","current":-58.334546,"twenty":-47.846928,"median":-32.115501,"eighty":-32.115501,"marketCap":5075455475},{"date":"2021-04-23","current":-56.879709,"twenty":-59.062279,"median":-56.339795,"eighty":-40.143004,"marketCap":4948875976},{"date":"2021-04-30","current":-63.644298,"twenty":-61.178557,"median":-58.334546,"eighty":-53.630508,"marketCap":5537435766},{"date":"2021-05-07","current":-52.840011,"twenty":-62.561963,"median":-58.94099,"eighty":-53.045807,"marketCap":4597398017},{"date":"2021-05-14","current":-35.902007,"twenty":-61.92552,"median":-56.879709,"eighty":-39.880725,"marketCap":3565033379},{"date":"2021-05-21","current":-42.801023,"twenty":-61.029927,"median":-53.097256,"eighty":-37.2852,"marketCap":4250098811},{"date":"2021-05-28","current":-44.682573,"twenty":-59.856128,"median":-44.682573,"eighty":-38.03443,"marketCap":4436934838},{"date":"2021-06-04","current":-49.869549,"twenty":-59.730364,"median":-48.276164,"eighty":-38.587029,"marketCap":4951996317},{"date":"2021-06-11","current":-52.937662,"twenty":-59.304856,"median":-49.547482,"eighty":-39.105727,"marketCap":5256656866},{"date":"2021-06-18","current":-61.75213,"twenty":-59.517138,"median":-51.191719,"eighty":-40.956765,"marketCap":6131924740},{"date":"2021-06-25","current":-57.24319,"twenty":-59.730364,"median":-52.512135,"eighty":-41.61785,"marketCap":5684191558},{"date":"2021-07-02","current":-62.209804,"twenty":-61.602962,"median":-53.354501,"eighty":-41.973819,"marketCap":6177371341},{"date":"2021-07-09","current":-68.057865,"twenty":-62.024607,"median":-55.799882,"eighty":-42.801023,"marketCap":6758077911},{"date":"2021-07-16","current":-55.971873,"twenty":-62.209804,"median":-56.090529,"eighty":-42.834925,"marketCap":5557950999},{"date":"2021-07-23","current":-59.429856,"twenty":-62.024607,"median":-56.802467,"eighty":-43.179036,"marketCap":5901325319},{"date":"2021-07-30","current":-51.445982,"twenty":-61.870786,"median":-56.251562,"eighty":-43.903132,"marketCap":5108534610},{"date":"2021-08-06","current":-48.157508,"twenty":-61.77689,"median":-55.799882,"eighty":-44.682573,"marketCap":4781992365},{"date":"2021-08-13","current":-30.590777,"twenty":-61.75213,"median":-55.166705,"eighty":-43.903132,"marketCap":3785822761},{"date":"2021-08-20","current":-27.023895,"twenty":-61.00629,"median":-53.354501,"eighty":-41.767018,"marketCap":3344396164},{"date":"2021-08-27","current":-30.645233,"twenty":-61.00629,"median":-53.039367,"eighty":-38.681955,"marketCap":3792562099},{"date":"2021-09-03","current":-36.771557,"twenty":-61.00629,"median":-52.184258,"eighty":-36.771557,"marketCap":4550737552},{"date":"2021-09-10","current":-38.514156,"twenty":-60.62659,"median":-51.598541,"eighty":-36.703487,"marketCap":4766396347},{"date":"2021-09-17","current":-36.499276,"twenty":-60.033919,"median":-51.251047,"eighty":-35.871495,"marketCap":4517040865},{"date":"2021-09-24","current":-33.381658,"twenty":-59.802773,"median":-50.513683,"eighty":-35.431934,"marketCap":4131213801},{"date":"2021-10-01","current":-29.76032,"twenty":-59.593166,"median":-48.750789,"eighty":-33.705672,"marketCap":3683047867},{"date":"2021-10-08","current":-25.431051,"twenty":-59.453372,"median":-48.157508,"eighty":-33.348984,"marketCap":3147270547},{"date":"2021-10-15","current":-25.921157,"twenty":-59.402735,"median":-45.826759,"eighty":-32.115501,"marketCap":3207924583},{"date":"2021-10-22","current":-24.192172,"twenty":-59.219665,"median":-44.394408,"eighty":-30.634342,"marketCap":2993950622},{"date":"2021-10-29","current":-26.070911,"twenty":-59.039986,"median":-43.00698,"eighty":-29.708587,"marketCap":3226457761},{"date":"2021-11-05","current":-26.16621,"twenty":-58.468854,"median":-41.767018,"eighty":-28.720206,"marketCap":3238251601},{"date":"2021-11-12","current":-21.544001,"twenty":-58.039592,"median":-40.025065,"eighty":-27.448654,"marketCap":3173689910},{"date":"2021-11-19","current":-22.725594,"twenty":-57.428405,"median":-38.681955,"eighty":-27.078351,"marketCap":3347752776},{"date":"2021-11-26","current":-21.693134,"twenty":-57.263531,"median":-38.514156,"eighty":-26.781565,"marketCap":3195659010},{"date":"2021-12-03","current":-20.327993,"twenty":-57.141485,"median":-37.351309,"eighty":-26.324132,"marketCap":2994557253},{"date":"2021-12-10","current":-21.773437,"twenty":-56.957298,"median":-36.499276,"eighty":-26.011009,"marketCap":3207488525},{"date":"2021-12-17","current":-20.832751,"twenty":-56.833364,"median":-36.084922,"eighty":-25.365703,"marketCap":3068914205},{"date":"2021-12-23","current":-19.249645,"twenty":-56.66686,"median":-35.724023,"eighty":-25.05258,"marketCap":2835703764},{"date":"2021-12-31","current":-19.651158,"twenty":-56.395645,"median":-35.519064,"eighty":-24.241182,"marketCap":2894851340},{"date":"2022-01-07","current":-18.125411,"twenty":-56.260038,"median":-34.511624,"eighty":-22.725594,"marketCap":2670090553},{"date":"2022-01-14","current":-15.842527,"twenty":-56.11426,"median":-33.585868,"eighty":-22.188715,"marketCap":2333794338},{"date":"2022-01-21","current":-12.905752,"twenty":-55.937475,"median":-33.49057,"eighty":-21.83309,"marketCap":1901172071},{"date":"2022-01-28","current":-12.309219,"twenty":-55.746135,"median":-33.122991,"eighty":-21.693134,"marketCap":1813295673},{"date":"2022-02-04","current":-13.077828,"twenty":-55.476906,"median":-32.115501,"eighty":-21.516469,"marketCap":1926521032},{"date":"2022-02-11","current":-13.754663,"twenty":-55.222643,"median":-31.264672,"eighty":-20.864872,"marketCap":2026226945},{"date":"2022-02-18","current":-11.701215,"twenty":-55.029403,"median":-30.590777,"eighty":-20.348642,"marketCap":1723729344},{"date":"2022-02-25","current":-12.320691,"twenty":-54.853113,"median":-29.950916,"eighty":-20.05267,"marketCap":1814985604},{"date":"2022-03-04","current":-8.775911,"twenty":-53.354501,"median":-29.454003,"eighty":-19.249645,"marketCap":1292797008},{"date":"2022-03-11","current":-7.743451,"twenty":-53.191925,"median":-28.861792,"eighty":-18.756359,"marketCap":1140703242},{"date":"2022-03-18","current":-8.225266,"twenty":-53.141072,"median":-27.983685,"eighty":-18.045109,"marketCap":1211680333},{"date":"2022-03-25","current":-6.190668,"twenty":-52.937662,"median":-27.350632,"eighty":-15.842527,"marketCap":1154429495},{"date":"2022-04-01","current":-7.042342,"twenty":-52.840011,"median":-27.091965,"eighty":-14.075873,"marketCap":1313248937},{"date":"2022-04-08","current":-6.089932,"twenty":-52.184258,"median":-26.87414,"eighty":-13.582587,"marketCap":1135644400},{"date":"2022-04-14","current":-6.831713,"twenty":-52.095384,"median":-26.683544,"eighty":-13.460985,"marketCap":1273971011},{"date":"2022-04-22","current":-5.494675,"twenty":-51.693466,"median":-26.404455,"eighty":-13.160425,"marketCap":1024641564},{"date":"2022-04-29","current":-5.707831,"twenty":-51.476494,"median":-26.16621,"eighty":-12.866748,"marketCap":1064390580},{"date":"2022-05-06","current":-5.578944,"twenty":-51.296815,"median":-25.996034,"eighty":-12.339045,"marketCap":1040355954},{"date":"2022-05-13","current":-4.581642,"twenty":-51.245962,"median":-25.66249,"eighty":-12.100432,"marketCap":970121544},{"date":"2022-05-20","current":-4.394802,"twenty":-51.20189,"median":-25.220033,"eighty":-11.412126,"marketCap":930559850},{"date":"2022-05-27","current":-5.012187,"twenty":-50.64929,"median":-25.009015,"eighty":-8.35375,"marketCap":1061285448},{"date":"2022-06-03","current":-5.808288,"twenty":-50.127203,"median":-24.859261,"eighty":-8.087604,"marketCap":1229852666},{"date":"2022-06-10","current":-5.264015,"twenty":-49.483068,"median":-23.980849,"eighty":-7.571374,"marketCap":1114607731},{"date":"2022-06-17","current":-6.190091,"twenty":-48.655864,"median":-22.725594,"eighty":-7.07403,"marketCap":1310696128},{"date":"2022-06-24","current":-7.303008,"twenty":-48.235482,"median":-22.656764,"eighty":-7.052052,"marketCap":1546346220},{"date":"2022-07-01","current":-6.848093,"twenty":-48.167679,"median":-22.203629,"eighty":-6.817171,"marketCap":1450022095},{"date":"2022-07-08","current":-7.278638,"twenty":-48.052412,"median":-21.997137,"eighty":-6.834989,"marketCap":1541185999},{"date":"2022-07-15","current":-6.904958,"twenty":-47.499813,"median":-21.773437,"eighty":-6.702198,"marketCap":1462062611},{"date":"2022-07-22","current":-6.360684,"twenty":-46.513271,"median":-21.693134,"eighty":-6.662878,"marketCap":1346817675},{"date":"2022-07-29","current":-6.872464,"twenty":-44.662232,"median":-21.566945,"eighty":-6.62551,"marketCap":1455182316},{"date":"2022-08-05","current":-8.050368,"twenty":-44.543576,"median":-21.435019,"eighty":-6.646631,"marketCap":1704592997},{"date":"2022-08-12","current":-8.909121,"twenty":-44.296153,"median":-20.993356,"eighty":-6.646631,"marketCap":2083843359},{"date":"2022-08-19","current":-7.25161,"twenty":-43.758313,"median":-20.677882,"eighty":-6.662878,"marketCap":1696151571},{"date":"2022-08-26","current":-7.80658,"twenty":-43.110214,"median":-20.327993,"eighty":-6.702198,"marketCap":1825959090},{"date":"2022-09-02","current":-7.569793,"twenty":-42.828145,"median":-20.05267,"eighty":-6.706427,"marketCap":1770574548},{"date":"2022-09-09","current":-9.819272,"twenty":-42.801023,"median":-19.530704,"eighty":-6.718117,"marketCap":2296727689},{"date":"2022-09-16","current":-7.99157,"twenty":-41.767018,"median":-19.249645,"eighty":-6.742488,"marketCap":1869228262},{"date":"2022-09-23","current":-7.984171,"twenty":-41.580558,"median":-19.014474,"eighty":-6.807476,"marketCap":1867497495},{"date":"2022-09-30","current":-7.873177,"twenty":-40.800817,"median":-18.653113,"eighty":-6.831713,"marketCap":1841535992},{"date":"2022-10-07","current":-7.976771,"twenty":-39.249314,"median":-18.08526,"eighty":-6.848093,"marketCap":1865766728},{"date":"2022-10-14","current":-7.762183,"twenty":-38.97012,"median":-17.001177,"eighty":-6.872464,"marketCap":1815574488},{"date":"2022-10-21","current":-8.228357,"twenty":-38.681955,"median":-15.068182,"eighty":-6.896834,"marketCap":1924612803},{"date":"2022-10-28","current":-8.206159,"twenty":-38.563298,"median":-14.156175,"eighty":-6.904958,"marketCap":1919420503},{"date":"2022-11-04","current":-7.133216,"twenty":-38.514156,"median":-13.89806,"eighty":-6.953698,"marketCap":1668459301},{"date":"2022-11-11","current":-9.580773,"twenty":-38.378015,"median":-13.582587,"eighty":-6.955626,"marketCap":2365655697},{"date":"2022-11-18","current":-7.538717,"twenty":-37.681851,"median":-13.50802,"eighty":-7.042342,"marketCap":1861437415},{"date":"2022-11-25","current":-7.108811,"twenty":-37.152983,"median":-13.335943,"eighty":-7.027999,"marketCap":1755286198},{"date":"2022-12-02","current":-7.147195,"twenty":-36.821399,"median":-13.181074,"eighty":-6.967626,"marketCap":1764763985},{"date":"2022-12-09","current":-6.617489,"twenty":-36.553732,"median":-12.99179,"eighty":-6.967626,"marketCap":1633970521},{"date":"2022-12-16","current":-6.471628,"twenty":-36.444819,"median":-12.710731,"eighty":-6.903333,"marketCap":1597954930},{"date":"2022-12-23","current":-5.765353,"twenty":-36.300511,"median":-12.372314,"eighty":-6.827253,"marketCap":1423563644},{"date":"2022-12-30","current":-5.918891,"twenty":-36.048339,"median":-12.320691,"eighty":-6.794058,"marketCap":1461474793},{"date":"2023-01-06","current":-5.711615,"twenty":-35.840984,"median":-12.25186,"eighty":-6.709349,"marketCap":1410294742},{"date":"2023-01-13","current":-6.678904,"twenty":-35.729108,"median":-11.701215,"eighty":-6.66344,"marketCap":1649134981},{"date":"2023-01-20","current":-6.64052,"twenty":-35.66269,"median":-11.483251,"eighty":-6.646631,"marketCap":1639657194},{"date":"2023-01-27","current":-6.556074,"twenty":-35.519064,"median":-10.015362,"eighty":-6.618118,"marketCap":1618806062},{"date":"2023-02-03","current":-7.400533,"twenty":-35.431934,"median":-9.819272,"eighty":-6.606014,"marketCap":1827317381},{"date":"2023-02-10","current":-6.287382,"twenty":-35.004453,"median":-9.645381,"eighty":-6.59378,"marketCap":1552461551},{"date":"2023-02-17","current":-6.133844,"twenty":-34.617814,"median":-9.493689,"eighty":-6.556255,"marketCap":1514550402},{"date":"2023-02-24","current":-5.842122,"twenty":-34.334641,"median":-9.104805,"eighty":-6.520348,"marketCap":1442519219},{"date":"2023-03-03","current":-6.771673,"twenty":-33.735623,"median":-8.837897,"eighty":-6.508153,"marketCap":1621653202},{"date":"2023-03-10","current":-5.645723,"twenty":-33.585868,"median":-8.761129,"eighty":-6.502335,"marketCap":1352015111},{"date":"2023-03-17","current":-5.917229,"twenty":-33.55864,"median":-8.632225,"eighty":-6.468226,"marketCap":1417034225},{"date":"2023-03-24","current":-5.342275,"twenty":-33.49057,"median":-8.529037,"eighty":-6.394859,"marketCap":1279346689},{"date":"2023-03-31","current":-5.326304,"twenty":-33.381658,"median":-8.384524,"eighty":-6.370676,"marketCap":1275522035},{"date":"2023-04-06","current":-5.150624,"twenty":-33.250963,"median":-8.261655,"eighty":-6.344393,"marketCap":1233450844},{"date":"2023-04-14","current":-5.230479,"twenty":-33.065811,"median":-8.206159,"eighty":-6.298729,"marketCap":1252574112},{"date":"2023-04-21","current":-4.344092,"twenty":-32.774471,"median":-8.167907,"eighty":-6.267962,"marketCap":1040305828},{"date":"2023-04-28","current":-3.904892,"twenty":-32.311563,"median":-8.118028,"eighty":-6.189087,"marketCap":935127849},{"date":"2023-05-05","current":-4.127735,"twenty":-32.115501,"median":-8.080365,"eighty":-6.130932,"marketCap":988493466},{"date":"2023-05-12","current":-4.173613,"twenty":-31.641762,"median":-8.069266,"eighty":-6.103512,"marketCap":1038495081},{"date":"2023-05-19","current":-4.228715,"twenty":-31.25242,"median":-8.058167,"eighty":-6.088073,"marketCap":1052205808},{"date":"2023-05-26","current":-6.694821,"twenty":-30.868503,"median":-8.050567,"eighty":-6.088073,"marketCap":1665832230},{"date":"2023-06-02","current":-6.77986,"twenty":-30.623451,"median":-8.039668,"eighty":-6.089932,"marketCap":1686991762},{"date":"2023-06-09","current":-7.065897,"twenty":-30.405626,"median":-8.018774,"eighty":-6.091123,"marketCap":1758164733},{"date":"2023-06-16","current":-7.189589,"twenty":-30.057106,"median":-7.980471,"eighty":-6.093929,"marketCap":1788942234},{"date":"2023-06-23","current":-5.960401,"twenty":-29.912797,"median":-7.958272,"eighty":-6.093419,"marketCap":1483090819},{"date":"2023-06-30","current":-5.705287,"twenty":-29.76032,"median":-7.941617,"eighty":-6.085284,"marketCap":1419612224},{"date":"2023-07-07","current":-5.094558,"twenty":-29.553386,"median":-7.928674,"eighty":-6.021762,"marketCap":1267648314},{"date":"2023-07-14","current":-9.998302,"twenty":-29.425414,"median":-7.924974,"eighty":-6.000489,"marketCap":2487817514},{"date":"2023-07-21","current":-11.907909,"twenty":-29.123182,"median":-7.941617,"eighty":-6.003337,"marketCap":2962973653},{"date":"2023-07-28","current":-10.380224,"twenty":-28.899911,"median":-7.969371,"eighty":-6.021762,"marketCap":2582848742},{"date":"2023-08-04","current":-9.950059,"twenty":-28.295447,"median":-7.98787,"eighty":-6.059865,"marketCap":2475813569},{"date":"2023-08-11","current":-8.275591,"twenty":-28.077623,"median":-8.035968,"eighty":-6.077733,"marketCap":2151570954},{"date":"2023-08-18","current":-7.28053,"twenty":-27.938759,"median":-7.98787,"eighty":-6.084248,"marketCap":1892865028},{"date":"2023-08-25","current":-7.106394,"twenty":-27.560289,"median":-7.969371,"eighty":-6.089002,"marketCap":1847591491},{"date":"2023-09-01","current":-7.214193,"twenty":-27.375137,"median":-7.941617,"eighty":-6.089932,"marketCap":1875617966},{"date":"2023-09-08","current":-6.932259,"twenty":-27.277116,"median":-7.933993,"eighty":-6.091718,"marketCap":1802317953},{"date":"2023-09-15","current":-7.131271,"twenty":-27.146421,"median":-7.873177,"eighty":-6.09444,"marketCap":1854059139},{"date":"2023-09-22","current":-6.608864,"twenty":-27.091965,"median":-7.821379,"eighty":-6.103512,"marketCap":1718238527},{"date":"2023-09-29","current":-6.44302,"twenty":-27.051123,"median":-7.80658,"eighty":-6.118463,"marketCap":1675120873},{"date":"2023-10-06","current":-5.895737,"twenty":-26.934042,"median":-7.777522,"eighty":-6.09444,"marketCap":1532832613},{"date":"2023-10-13","current":-5.248947,"twenty":-26.857803,"median":-7.762183,"eighty":-6.083213,"marketCap":1364673761},{"date":"2023-10-20","current":-5.016766,"twenty":-26.748891,"median":-7.715647,"eighty":-6.003337,"marketCap":1304309045},{"date":"2023-10-27","current":-4.602157,"twenty":-26.683544,"median":-7.693671,"eighty":-5.989098,"marketCap":1196514909},{"date":"2023-11-03","current":-4.336808,"twenty":-26.574631,"median":-7.665988,"eighty":-5.973127,"marketCap":1127526662},{"date":"2023-11-10","current":-3.872477,"twenty":-26.452105,"median":-7.62151,"eighty":-5.937198,"marketCap":1132939550},{"date":"2023-11-17","current":-4.938704,"twenty":-26.356806,"median":-7.594318,"eighty":-5.918891,"marketCap":1444877017},{"date":"2023-11-24","current":-5.079386,"twenty":-26.291459,"median":-7.562464,"eighty":-5.894282,"marketCap":1486035433},{"date":"2023-12-01","current":-5.071982,"twenty":-26.187992,"median":-7.537838,"eighty":-5.86155,"marketCap":1483869200},{"date":"2023-12-08","current":-5.582882,"twenty":-26.089971,"median":-7.522342,"eighty":-5.835247,"marketCap":1633339237},{"date":"2023-12-15","current":-7.056349,"twenty":-26.070911,"median":-7.429201,"eighty":-5.826916,"marketCap":2064419486},{"date":"2023-12-22","current":-7.285884,"twenty":-25.951108,"median":-7.414401,"eighty":-5.829021,"marketCap":2131572691},{"date":"2023-12-29","current":-7.856019,"twenty":-25.915711,"median":-7.427886,"eighty":-5.832323,"marketCap":2298372587},{"date":"2024-01-05","current":-8.226237,"twenty":-25.907543,"median":-7.421801,"eighty":-5.836709,"marketCap":2406684207},{"date":"2024-01-12","current":-8.329897,"twenty":-25.66249,"median":-7.47051,"eighty":-5.842122,"marketCap":2437011461},{"date":"2024-01-19","current":-7.322905,"twenty":-25.477339,"median":-7.513381,"eighty":-5.842122,"marketCap":2142403853},{"date":"2024-01-26","current":-7.574653,"twenty":-25.300356,"median":-7.529295,"eighty":-5.854405,"marketCap":2216055755},{"date":"2024-02-02","current":-7.071157,"twenty":-25.191444,"median":-7.513381,"eighty":-5.86155,"marketCap":2068751951},{"date":"2024-02-09","current":-7.33031,"twenty":-25.128819,"median":-7.433971,"eighty":-5.864636,"marketCap":2144570085},{"date":"2024-02-16","current":-9.203611,"twenty":-25.030798,"median":-7.453796,"eighty":-5.883577,"marketCap":2692626885},{"date":"2024-02-23","current":-11.10653,"twenty":-25.000847,"median":-7.513381,"eighty":-5.888349,"marketCap":3249348615},{"date":"2024-03-01","current":-8.88769,"twenty":-24.913717,"median":-7.536959,"eighty":-5.892826,"marketCap":2915748823},{"date":"2024-03-08","current":-7.990835,"twenty":-24.532523,"median":-7.555029,"eighty":-5.908632,"marketCap":2621521334},{"date":"2024-03-15","current":-7.725668,"twenty":-24.241182,"median":-7.562464,"eighty":-5.918226,"marketCap":2534529146},{"date":"2024-03-22","current":-7.632502,"twenty":-23.938584,"median":-7.584485,"eighty":-5.918891,"marketCap":2503964323},{"date":"2024-03-28","current":-7.288502,"twenty":-23.439139,"median":-7.566128,"eighty":-5.924614,"marketCap":2391109593},{"date":"2024-04-05","current":-6.256501,"twenty":-22.856372,"median":-7.547594,"eighty":-5.933617,"marketCap":2052545403},{"date":"2024-04-12","current":-6.392668,"twenty":-22.725594,"median":-7.537838,"eighty":-5.934247,"marketCap":2097217067},{"date":"2024-04-19","current":-5.303335,"twenty":-22.698062,"median":-7.522342,"eighty":-5.918891,"marketCap":1739843755},{"date":"2024-04-26","current":-5.687229,"twenty":-22.509925,"median":-7.487706,"eighty":-5.888294,"marketCap":1865786343},{"date":"2024-05-03","current":-6.37637,"twenty":-22.285078,"median":-7.433971,"eighty":-5.888294,"marketCap":2091870148},{"date":"2024-05-10","current":-6.267558,"twenty":-22.218542,"median":-7.418101,"eighty":-5.889214,"marketCap":2056172705},{"date":"2024-05-17","current":-6.382694,"twenty":-22.10153,"median":-7.396002,"eighty":-5.889214,"marketCap":2260188615},{"date":"2024-05-24","current":-6.060539,"twenty":-22.009755,"median":-7.373614,"eighty":-5.892501,"marketCap":2146109694},{"date":"2024-05-31","current":-5.953154,"twenty":-21.908804,"median":-7.332906,"eighty":-5.891423,"marketCap":2108083387},{"date":"2024-06-07","current":-6.047116,"twenty":-21.800969,"median":-7.322905,"eighty":-5.888238,"marketCap":2141356406},{"date":"2024-06-14","current":-6.335713,"twenty":-21.773437,"median":-7.303407,"eighty":-5.865153,"marketCap":2243552105},{"date":"2024-06-21","current":-6.141078,"twenty":-21.773437,"median":-7.303008,"eighty":-5.883577,"marketCap":2174629424},{"date":"2024-06-28","current":-5.738877,"twenty":-21.757376,"median":-7.303008,"eighty":-5.869759,"marketCap":2032205183},{"date":"2024-07-05","current":-5.566859,"twenty":-21.693134,"median":-7.288502,"eighty":-5.842122,"marketCap":1971291403},{"date":"2024-07-12","current":-5.816799,"twenty":-21.693134,"median":-7.283207,"eighty":-5.827511,"marketCap":2059798364},{"date":"2024-07-15","current":-6.331828,"twenty":-21.677074,"median":-7.28053,"eighty":-5.827889,"marketCap":2242176344},{"date":"2024-08-02","current":-5.559285,"twenty":-21.661013,"median":-7.279584,"eighty":-5.825725,"marketCap":1968609374},{"date":"2024-08-09","current":-4.749917,"twenty":-21.594477,"median":-7.25161,"eighty":-5.796615,"marketCap":1780867335},{"date":"2024-08-16","current":-5.013463,"twenty":-21.557767,"median":-7.227678,"eighty":-5.772377,"marketCap":1879677766},{"date":"2024-08-23","current":-5.508065,"twenty":-21.530235,"median":-7.214193,"eighty":-5.759019,"marketCap":2065116828},{"date":"2024-08-30","current":-5.553029,"twenty":-21.449933,"median":-7.191423,"eighty":-5.72252,"marketCap":2081974925},{"date":"2024-09-06","current":-4.623777,"twenty":-21.328332,"median":-7.189279,"eighty":-5.708345,"marketCap":1733574262},{"date":"2024-09-13","current":-4.871078,"twenty":-21.15855,"median":-7.174818,"eighty":-5.703384,"marketCap":1826293794},{"date":"2024-09-20","current":-5.200813,"twenty":-20.961235,"median":-7.166206,"eighty":-5.674587,"marketCap":1949919835},{"date":"2024-09-27","current":-5.373174,"twenty":-20.802924,"median":-7.150935,"eighty":-5.651287,"marketCap":2014542538},{"date":"2024-10-04","current":-4.541343,"twenty":-20.681324,"median":-7.144123,"eighty":-5.637453,"marketCap":1702667752},{"date":"2024-10-11","current":-4.631271,"twenty":-20.623965,"median":-7.139563,"eighty":-5.608986,"marketCap":1736383945},{"date":"2024-10-18","current":-4.908548,"twenty":-20.41059,"median":-7.132243,"eighty":-5.58344,"marketCap":1840342207},{"date":"2024-10-25","current":-4.766162,"twenty":-20.323404,"median":-7.130392,"eighty":-5.573856,"marketCap":1786958235},{"date":"2024-10-31","current":-5.005969,"twenty":-20.305049,"median":-7.114687,"eighty":-5.559285,"marketCap":1876868083},{"date":"2024-11-08","current":-5.262167,"twenty":-20.05267,"median":-7.106394,"eighty":-5.527369,"marketCap":1987788975},{"date":"2024-11-15","current":-5.246981,"twenty":-20.05267,"median":-7.093457,"eighty":-5.523053,"marketCap":1982052210},{"date":"2024-11-22","current":-4.366156,"twenty":-19.651158,"median":-7.076099,"eighty":-5.496661,"marketCap":1649319857},{"date":"2024-11-29","current":-5.368474,"twenty":-19.458432,"median":-7.072192,"eighty":-5.484495,"marketCap":2027946328},{"date":"2024-12-06","current":-5.003995,"twenty":-19.382718,"median":-7.065897,"eighty":-5.453819,"marketCap":1890263975},{"date":"2024-12-13","current":-5.300134,"twenty":-19.274883,"median":-7.044868,"eighty":-5.453819,"marketCap":2002130887},{"date":"2024-12-20","current":-4.624329,"twenty":-19.212935,"median":-7.011782,"eighty":-5.426221,"marketCap":1746844857},{"date":"2024-12-27","current":-5.816479,"twenty":-19.14181,"median":-7.004518,"eighty":-5.425958,"marketCap":2197180887},{"date":"2025-01-03","current":-5.47478,"twenty":-19.031682,"median":-6.997114,"eighty":-5.418488,"marketCap":2068103681},{"date":"2025-01-10","current":-5.512747,"twenty":-18.894021,"median":-6.98598,"eighty":-5.425431,"marketCap":2082445593},{"date":"2025-01-17","current":-4.859722,"twenty":-18.73571,"median":-6.969061,"eighty":-5.406215,"marketCap":1835764710},{"date":"2025-01-24","current":-7.862234,"twenty":-18.653113,"median":-6.978303,"eighty":-5.40644,"marketCap":2969966606},{"date":"2025-01-31","current":-8.029293,"twenty":-18.515452,"median":-6.993657,"eighty":-5.406498,"marketCap":3033073466},{"date":"2025-02-07","current":-7.559438,"twenty":-18.125411,"median":-7.001557,"eighty":-5.414034,"marketCap":2855585422},{"date":"2025-02-14","current":-8.875031,"twenty":-18.045109,"median":-7.011782,"eighty":-5.425168,"marketCap":3352551946},{"date":"2025-02-21","current":-10.806656,"twenty":-17.778963,"median":-7.042342,"eighty":-5.426221,"marketCap":4082225016},{"date":"2025-02-28","current":-8.008411,"twenty":-17.143427,"median":-7.061123,"eighty":-5.430397,"marketCap":3025185108},{"date":"2025-03-07","current":-5.414026,"twenty":-16.156854,"median":-7.042342,"eighty":-5.430397,"marketCap":2510272533},{"date":"2025-03-14","current":-5.153736,"twenty":-15.863176,"median":-7.010397,"eighty":-5.414032,"marketCap":2389586354},{"date":"2025-03-21","current":-5.622257,"twenty":-14.603575,"median":-6.998596,"eighty":-5.422941,"marketCap":2606821477},{"date":"2025-03-28","current":-5.179765,"twenty":-14.202063,"median":-6.989819,"eighty":-5.414032,"marketCap":2401654972},{"date":"2025-04-04","current":-4.173311,"twenty":-14.160764,"median":-6.970626,"eighty":-5.403178,"marketCap":1935001744},{"date":"2025-04-11","current":-3.913022,"twenty":-14.091933,"median":-6.954662,"eighty":-5.372463,"marketCap":1814315565},{"date":"2025-04-17","current":-4.615804,"twenty":-14.055224,"median":-6.937232,"eighty":-5.367577,"marketCap":2140168249},{"date":"2025-04-25","current":-4.988886,"twenty":-13.869381,"median":-6.907382,"eighty":-5.353417,"marketCap":2313151773},{"date":"2025-05-02","current":-4.771978,"twenty":-13.692715,"median":-6.900193,"eighty":-5.326304,"marketCap":2212579957},{"date":"2025-05-09","current":-3.107935,"twenty":-13.610119,"median":-6.878644,"eighty":-5.313929,"marketCap":1786363373},{"date":"2025-05-16","current":-3.008821,"twenty":-13.548172,"median":-6.855621,"eighty":-5.296244,"marketCap":1729395065},{"date":"2025-05-23","current":-2.934485,"twenty":-13.525228,"median":-6.818513,"eighty":-5.266107,"marketCap":1686668834},{"date":"2025-05-30","current":-3.150413,"twenty":-13.511462,"median":-6.809411,"eighty":-5.257395,"marketCap":1810778362},{"date":"2025-06-05","current":-3.476073,"twenty":-13.460985,"median":-6.801735,"eighty":-5.247374,"marketCap":1997959946}],"updateTime":1749258638048}}}